Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation

Toxicology and Applied Pharmacology

Volumn 235, Issue 1, 2009, Pages 39-46

  Jensen, Taylor J ^a,b   Wozniak, Ryan J ^a,b   Eblin, Kylee E ^a   Wnek, Sean M ^a   Gandolfi, A Jay ^a   Futscher, Bernard W ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arsenic; Epigenetic; Histone modification; UROtsa; WNT5A

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; HISTONE; METHANEARSONIC ACID; SHORT HAIRPIN RNA;

ACETYLATION; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BLADDER CANCER; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EPIGENETICS; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LENTIVIRINAE; MALIGNANT TRANSFORMATION; PROMOTER REGION; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UROTHELIUM; WNT5A GENE;

ARSENICALS; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; GENE SILENCING; HISTONES; HUMANS; MUTATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 59349117680     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.10.013     Document Type: Article

References (51)

1. Ahlborn G.J., Nelson G.M., Ward W.O., Knapp G., Allen J.W., Ouyang M., Roop B.C., Chen Y., O'Brien T., Kitchin K.T., and Delker D.A. Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite. Toxicol. Appl. Pharmacol. 227 (2008) 400-416
2. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 397-419
3. Bachmann I.M., Halvorsen O.J., Collett K., Stefansson I.M., Straume O., Haukaas S.A., Salvesen H.B., Otte A.P., and Akslen L.A. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 24 (2006) 268-273
4. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., Sampas N., Dougherty E., Wang E., Marincola F., Gooden C., Lueders J., Glatfelter A., Pollock P., Carpten J., Gillanders E., Leja D., Dietrich K., Beaudry C., Berens M., Alberts D., and Sondak V. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 (2000) 536-540
5. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., Bell G.W., Otte A.P., Vidal M., Gifford D.K., Young R.A., and Jaenisch R. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441 (2006) 349-353
6. Bredfeldt T.G., Jagadish B., Eblin K.E., Mash E.A., and Gandolfi A.J. Monomethylarsonous acid induces transformation of human bladder cells. Toxicol. Appl. Pharmacol. 216 (2006) 69-79
7. Cao R., and Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15 (2004) 57-67
8. Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P., Jones R.S., and Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298 (2002) 1039-1043
9. Cha T.L., Zhou B.P., Xia W., Wu Y., Yang C.C., Chen C.T., Ping B., Otte A.P., and Hung M.C. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310 (2005) 306-310
10. Chen C.J., Kuo T.L., and Wu M.M. Arsenic and cancers. Lancet 1 (1988) 414-415
11. Chen H., Li S., Liu J., Diwan B.A., Barrett J.C., and Waalkes M.P. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25 (2004) 1779-1786
12. Coolen M.W., Statham A.L., Gardiner-Garden M., and Clark S.J. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res. 35 (2007) e119
13. Dissanayake S.K., Wade M., Johnson C.E., O'Connell M.P., Leotlela P.D., French A.D., Shah K.V., Hewitt K.J., Rosenthal D.T., Indig F.E., Jiang Y., Nickoloff B.J., Taub D.D., Trent J.M., Moon R.T., Bittner M., and Weeraratna A.T. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem. 282 (2007) 17259-17271
14. Eblin K.E., Bowen M.E., Cromey D.W., Bredfeldt T.G., Mash E.A., Lau S.S., and Gandolfi A.J. Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. Toxicol. Appl. Pharmacol. 217 (2006) 7-14
15. Eblin K.E., Bredfeldt T.G., Buffington S., and Gandolfi A.J. Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis. Toxicol. Sci. 95 (2007) 321-330
16. Gal-Yam E.N., Egger G., Iniguez L., Holster H., Einarsson S., Zhang X., Lin J.C., Liang G., Jones P.A., and Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 12979-12984
17. Guo H.R., Chiang H.S., Hu H., Lipsitz S.R., and Monson R.R. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8 (1997) 545-550
18. Hei T.K., Liu S.X., and Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 8103-8107
19. Hopenhayn-Rich C., Biggs M.L., Fuchs A., Bergoglio R., Tello E.E., Nicolli H., and Smith A.H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7 (1996) 117-124
20. Huang C., Li J., Ding M., Wang L., Shi X., Castranova V., Vallyathan V., Ju G., and Costa M. Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells. Mol. Cell. Biochem. 222 (2001) 29-34
21. Jacobson-Kram D., and Montalbano D. The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ. Mutagen. 7 (1985) 787-804
22. Jensen T.J., Novak P., Eblin K.E., Gandolfi A.J., and Futscher B.W. Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis 29 (2008) 1500-1508
23. Kondo Y., Shen L., Cheng A.S., Ahmed S., Boumber Y., Charo C., Yamochi T., Urano T., Furukawa K., Kwabi-Addo B., Gold D.L., Sekido Y., Huang T.H., and Issa J.P. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40 (2008) 741-750
24. Kurayoshi M., Oue N., Yamamoto H., Kishida M., Inoue A., Asahara T., Yasui W., and Kikuchi A. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res. 66 (2006) 10439-10448
25. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., Koseki H., Fuchikami T., Abe K., Murray H.L., Zucker J.P., Yuan B., Bell G.W., Herbolsheimer E., Hannett N.M., Sun K., Odom D.T., Otte A.P., Volkert T.L., Bartel D.P., Melton D.A., Gifford D.K., Jaenisch R., and Young R.A. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125 (2006) 301-313
26. Lewis E.B. A gene complex controlling segmentation in Drosophila. Nature 276 (1978) 565-570
27. Liang H., Chen Q., Coles A.H., Anderson S.J., Pihan G., Bradley A., Gerstein R., Jurecic R., and Jones S.N. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4 (2003) 349-360
28. Ludwig S., Hoffmeyer A., Goebeler M., Kilian K., Hafner H., Neufeld B., Han J., and Rapp U.R. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem. 273 (1998) 1917-1922
29. Marshall G., Ferreccio C., Yuan Y., Bates M.N., Steinmaus C., Selvin S., Liaw J., and Smith A.H. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer Inst. 99 (2007) 920-928
30. Marsit C.J., Karagas M.R., Danaee H., Liu M., Andrew A., Schned A., Nelson H.H., and Kelsey K.T. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27 (2006) 112-116
31. Miller J.R., Hocking A.M., Brown J.D., and Moon R.T. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18 (1999) 7860-7872
32. Pasini D., Hansen K.H., Christensen J., Agger K., Cloos P.A., and Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev. 22 (2008) 1345-1355
33. Petzoldt J.L., Leigh I.M., Duffy P.G., Sexton C., and Masters J.R. Immortalisation of human urothelial cells. Urol. Res. 23 (1995) 377-380
34. Ripka S., Konig A., Buchholz M., Wagner M., Sipos B., Kloppel G., Downward J., Gress T., and Michl P. WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28 (2007) 1178-1187
35. Rossi M.R., Masters J.R., Park S., Todd J.H., Garrett S.H., Sens M.A., Somji S., Nath J., and Sens D.A. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ. Health Perspect. 109 (2001) 801-808
36. Schwerdtle T., Walter I., Mackiw I., and Hartwig A. Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24 (2003) 967-974
37. Sens D.A., Park S., Gurel V., Sens M.A., Garrett S.H., and Somji S. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol. Sci. 79 (2004) 56-63
38. Sheldahl L.C., Park M., Malbon C.C., and Moon R.T. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr. Biol. 9 (1999) 695-698
39. Sheldahl L.C., Slusarski D.C., Pandur P., Miller J.R., Kuhl M., and Moon R.T. Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J. Cell Biol. 161 (2003) 769-777
40. Simeonova P.P., Wang S., Kashon M.L., Kommineni C., Crecelius E., and Luster M.I. Quantitative relationship between arsenic exposure and AP-1 activity in mouse urinary bladder epithelium. Toxicol. Sci. 60 (2001) 279-284
41. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
42. Styblo M., Drobna Z., Jaspers I., Lin S., and Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 110 Suppl. 5 (2002) 767-771
43. Weeraratna A.T., Jiang Y., Hostetter G., Rosenblatt K., Duray P., Bittner M., and Trent J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1 (2002) 279-288
44. Wei Y., Xia W., Zhang Z., Liu J., Wang H., Adsay N.V., Albarracin C., Yu D., Abbruzzese J.L., Mills G.B., Bast Jr. R.C., Hortobagyi G.N., and Hung M.C. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol. Carcinog. 47 (2008) 701-706
45. Weikert S., Christoph F., Kollermann J., Muller M., Schrader M., Miller K., and Krause H. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int. J. Mol. Med. 16 (2005) 349-353
46. Ying J., Li H., Yu J., Ng K.M., Poon F.F., Wong S.C., Chan A.T., Sung J.J., and Tao Q. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin. Cancer Res. 14 (2008) 55-61
47. Yu J.M., Jun E.S., Jung J.S., Suh S.Y., Han J.Y., Kim J.Y., and Kim K.W. Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett. 257 (2007) 172-181
48. Zakharyan R.A., Ayala-Fierro F., Cullen W.R., Carter D.M., and Aposhian H.V. Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158 (1999) 9-15
49. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., and Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10907-10912
50. Zhou X., Sun H., Ellen T.P., Chen H., and Costa M. Arsenite alters global histone H3 methylation. Carcinogenesis 29 (2008) 1831-1836
51. Zhuang L., Zhang Z., and Guo Y. Aberrant expression of growth factor Wnt-5A in six urinary malignant cell lines. Chin. Med. J. (Engl.) 112 (1999) 251-255